W. Jeff Edenfield
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 1
- Cancer-related Molecular Pathways 1
- Colorectal Cancer Treatments and Studies 1
- Immunology top 10%
- Cancer Research top 10%
- Breast Cancer Treatment Studies 1
-
- Acute Myeloid Leukemia Research 1
-
- Neuroendocrine Tumor Research Advances 1
-
- Monoclonal and Polyclonal Antibodies Research 1
- Co-authors
- Anja von HeydebreckH. GroteKevin M. ChinRalph V. BocciaRobert A. SomerIstván TakácsGuy JérusalemPetros Nikolinakos
- Cited by
- OncologyImmunologyCancer Research
- Journals
- The Lancet Oncology (1 paper)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesGermanyHungary
In The Last Decade
W. Jeff Edenfield
5 papers receiving 874 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 758
- Immunology 278
- Cancer Research 175
- Pulmonary and Respiratory Medicine 300
- Pathology and Forensic Medicine 52
Countries citing papers authored by W. Jeff Edenfield
This map shows the geographic impact of W. Jeff Edenfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Jeff Edenfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Jeff Edenfield more than expected).
Fields of papers citing papers by W. Jeff Edenfield
This network shows the impact of papers produced by W. Jeff Edenfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Jeff Edenfield. The network helps show where W. Jeff Edenfield may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Jeff Edenfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 27 | |
| 2 | Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor studybreakdown → | 2017 | 581 |
| 3 | 2017 | 225 | |
| 4 | 2016 | 39 | |
| 5 | 2015 | 11 |
About W. Jeff Edenfield
W. Jeff Edenfield is a scholar working on Oncology, Hematology and Cancer Research, having authored 5 papers that have together received 883 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), HER2/EGFR in Cancer Research (1 paper), Acute Myeloid Leukemia Research (1 paper), Cancer-related Molecular Pathways (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Oncology (758 citations), Immunology (278 citations) and Cancer Research (175 citations). W. Jeff Edenfield has collaborated with scholars based in United States, Germany and Hungary. Frequent co-authors include Anja von Heydebreck, H. Grote, Kevin M. Chin, Ralph V. Boccia, Robert A. Somer, István Takács, Guy Jérusalem, Petros Nikolinakos, Andres Forero‐Torres and Leisha A. Emens. Their work appears in journals such as The Lancet Oncology, Clinical Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.